Azelaic acid Vertex (Cream) Instructions for Use
Marketing Authorization Holder
Vertex, JSC (Russia)
ATC Code
D10AX03 (Azelaic acid)
Active Substance
Azelaic acid (Rec.INN registered by WHO)
Dosage Form
| Azelaic acid Vertex | Cream for external use 20%: tubes 10 g, 15 g, 30 g, or 50 g |
Dosage Form, Packaging, and Composition
Cream for external use white, homogeneous.
| 1 g | |
| Azelaic acid | 200 mg |
Excipients: propylene glycol, isopropyl myristate, cetearyl alcohol (cetyl alcohol not more than 60%, stearyl alcohol not less than 40%), glyceryl monostearate, glycerol (glycerin), macrogol-20 cetearyl ether, cetyl palmitate, macrogol-6 cetearyl ether, benzoic acid, purified water.
10 g – aluminum tubes (1) – cardboard packs.
15 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Drug for the treatment of acne
Pharmacotherapeutic Group
Acne treatment agent
Pharmacological Action
Acne treatment agent. It has antimicrobial activity against Propionibacterium acne and Staphylococcus epidermidis.
In addition, it reduces the content of free fatty acids in skin lipids and normalizes impaired keratinization processes in the sebaceous gland follicles.
Pharmacokinetics
After application to the skin, Azelaic acid penetrates into the epidermis and dermis.
Part of the absorbed azelaic acid is excreted by the kidneys unchanged, and part in the form of dicarboxylic acids (C5, C7), formed from azelaic acid as a result of beta-oxidation.
Indications
Acne vulgaris, seborrheic dermatitis, rosacea (including in the presence of papules and pustules), pathological hyperpigmentation (including melasma).
ICD codes
| ICD-10 code | Indication |
| L21 | Seborrheic dermatitis |
| L70 | Acne |
| L71 | Rosacea |
| L81 | Pigmentation disorders |
| ICD-11 code | Indication |
| 1A61.3 | Secondary syphilis of skin or mucous membranes |
| EA81.Z | Seborrheic dermatitis, unspecified |
| EC23.0 | Non-syndromic genetically determined hypermelanosis or lentiginosis |
| ED60.1 | Melasma |
| ED60.2 | Postinflammatory hyperpigmentation |
| ED61.0 | Freckles |
| ED63.Y | Other specified acquired hypomelanotic disorders |
| ED80.Z | Acne, unspecified |
| EF40.0 | Capillaritis |
| EK5Y | Other specified skin lesions provoked by exposure to external factors |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Cleanse and dry affected skin areas thoroughly before each application.
Apply a thin layer of cream and gently massage into the skin twice daily, in the morning and evening.
Use the 20% cream for all indicated conditions, including acne vulgaris, rosacea, and hyperpigmentation.
The duration of therapy is set individually; clinical improvement in acne is typically observed after 4 weeks.
For rosacea, continue application for the full prescribed course to achieve optimal therapeutic effect.
If excessive skin irritation occurs, reduce application frequency to once daily until tolerance develops.
Resume twice-daily application as tolerated. Discontinue use if severe irritation persists.
Avoid contact with eyes, mouth, and other mucous membranes. Wash hands immediately after application.
Adverse Reactions
Local reactions rarely (mainly at the beginning of therapy) – skin irritation, erythema, burning sensation, itching, peeling (disappear on their own during further treatment).
Contraindications
Hypersensitivity to azelaic acid; children under 12 years of age for acne, children under 18 years of age – for rosacea.
Use in Pregnancy and Lactation
Use during pregnancy is possible if indicated.
Given the low systemic bioavailability and low toxicity of azelaic acid, use during lactation (breastfeeding) is possible.
In experimental studies on laboratory animals, no negative effect of azelaic acid on reproductive function was revealed, and no embryotoxic or teratogenic effects were established.
Pediatric Use
Contraindicated for use in children under 12 years of age for acne, in children under 18 years of age – for rosacea.
Special Precautions
Avoid contact with mucous membranes and eyes.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Belosalic, lotion solution for external use spray 100ml
No-spa pills 40mg, 64pcs
Arbidol, capsules 100mg, 40pcs
Noopept, pills 10mg, 50pcs
Fenotropil pills 100mg, 60pcs
Kagocel pills 12mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Mildronate capsules 500mg, 90pcs
Nootropil pills 800mg, 30pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Picamilon pills 50mg, 60pcs
Phenibut-Vertex pills 250mg, 20pcs
Actovegin pills 200mg, 50pcs
Belosalic, ointment, 30g
Ingavirin capsules 90mg, 10pcs 